Rex Wan-Hin Hui

Clinician-scientist @hkudeptmedicine @hkumed #Gastroenterology #Hepatology

[loeymak @loeymak]

The level of small HBs, the most abundant isoform of HBsAg in the blood of individuals with chronic hepatitis B infection, was predictive of HBsAg seroclearance after planned cessation of the nucleoside analogue. @JHEP_Reports @EASLedu @EASLnews @hkumed

https://t.co/GZBs9UqYda

[Rex Wan-Hin Hui @RexWHHui]

Our work was awarded Gold Medal (Original Research by Trainees) by the HK Academy of Medicine for 3 straight years🥇🥇🥇Carrying this momentum into 2026!

ft. my girl who likes the gold but always disturbs my work

MFYuen @WK_Seto @jamesyyfung @loeymak @hkudeptmedicine @hkumed

[Gut Journal @Gut_BMJ]

Excellent #GUTAbstract by @RexWHHui on the paper

"Large-scale profile study on hepatitis B surface antigen levels in chronic hepatitis B: implications for drug development targeting functional cure" via https://t.co/Bjsvj9dxM7

@hkumed @hkudeptmedicine @WK_Seto @IvanHung2 @loeymak @FrontGastro_BMJ #HBsAg #HepatitisB #CHB

[Rex Wan-Hin Hui @RexWHHui]

@Apichatka @JimmyLaiCT Thank you for your support!

[Rex Wan-Hin Hui @RexWHHui]

Celebrating a fruitful weekend where I received my Hong Kong College of Physicians fellowship, the Gold Medal for best thesis, and a Distinguished paper award
Also congratulations to @loeymak, @JimmyLaiCT and Michael Cheung for their great papers!

@hkudeptmedicine @hkumed

[Rex Wan-Hin Hui @RexWHHui]

We studied HBV integration patterns in different disease phases. Integrations associated with HCC were observed regardless of hepatitis activity, viremia level, and HBsAg positivity
Another reason to expand NUC treatment indication?
@WK_Seto @jamesyyfung @loeymak @hkumed

[JHEP Reports @JHEP_Reports]

🟣Profiles of HBV DNA integration in humans with hepatitis B virus infection: Insights for antiviral treatment

🔓#OpenAccess at👉https://t.co/7EsfwrCEVU

#HBV
#LiverX
#LiverTwitter

[loeymak @loeymak]

We studied Days At Home (DAH) reflecting the disease time burden. Immunotherapy gives HCC patients more DAH than tyrosine kinase inhibitor treatment. https://t.co/JQHQOcM1Dk
Congratulations to @RexWHHui @MattChungHKU @CarlosWongHKU @Ian_HKU @hkumed @JHEP_Reports

[Rex Wan-Hin Hui @RexWHHui]

@loeymak @WK_Seto @IvanHung2 @hkumed @hkudeptmedicine Thanks so much for the support! Glad to be a part of this great team😎

[Rex Wan-Hin Hui @RexWHHui]

Celebrating my PhD graduation with my supervisor Professor MF Yuen, and @WK_Seto @IvanHung2 @loeymak
Happy to wrap up this chapter and looking forward to more exciting science ahead
@hkumed @hkudeptmedicine

[Rex Wan-Hin Hui @RexWHHui]

@HenryHW_Liu @WK_Seto @IvanHung2 @loeymak @hkumed @hkudeptmedicine Thank you!

[Rex Wan-Hin Hui @RexWHHui]

@Apichatka @WK_Seto @IvanHung2 @loeymak @hkumed @hkudeptmedicine Thank you!

[HKU Medicine @hkumed]

HKUMed researchers have started clinical trials exploring a pioneering gene-related therapy for chronic hepatitis B infection, potentially allowing patients to stop long-term medication.

For more: https://t.co/r0FsNVHAgQ

[Hepatology International @hepinternation1]

A new article in Hepatology International examines emerging therapies for HBsAg seroclearance, with a focus on innovative novel combination strategies that hold promise for functional cure. This comprehensive review offers critical insights for clinicians and researchers alike.

🔗 Read the full article here: https://t.co/nUS0xCt5AT

#Hepatology #HepatitisB #HBsAgSeroclearance #NovelTherapies #CombinationTherapy #MedicalResearch #LiverHealth #HepatologyInternational #HealthcareProfessionals

[Rex Wan-Hin Hui @RexWHHui]

@Apichatka @WK_Seto @jamesyyfung @loeymak @hkumed @hkudeptmedicine Thank you!😃

[Rex Wan-Hin Hui @RexWHHui]

Our work has been awarded Gold Medal – Best Original Research by Trainees by The Hong Kong Academy of Medicine for the 2nd straight year🥇🥇

Grateful for 2024, and looking forward to a fruitful 2025!

Prof MF Yuen, @WK_Seto, @jamesyyfung , @loeymak
@hkumed @hkudeptmedicine

[Rex Wan-Hin Hui @RexWHHui]

@raudreylo @WK_Seto @jamesyyfung @loeymak @hkumed @hkudeptmedicine Thank you Regina!!

[loeymak @loeymak]

Our paper described the longitudinal profile of blood levels of HBV pregenomic RNA in CHB 🦠patients treated with long term NUC 💊now in press @CMH_journal

https://t.co/WpJdkpw3ZL

Clinical parameters eg age, gender, PAGE-B score and HBeAg can influence pgRNA levels #mfyuen

[Terry Cheuk-Fung Yip @TerryYip12]

The era of #AI and #XAI for liver diseases has come! #HKASLD #ASM2024 #HCC #BigData #EHRs @tung_hung @RexWHHui

[loeymak @loeymak]

Hepatology team from @hkudeptmedicine attending The Liver Meeting @AASLDtweets @AASLDFoundation @WK_Seto @jamesyyfung @RexWHHui

[Rex Wan-Hin Hui @RexWHHui]

Our paper on ALT/qHBsAg after stopping ETV has been awarded the Young Investigator Medal by the Hong Kong College of Physicians

Thankful as always to Professor MF Yuen, @WK_Seto @jamesyyfung @loeymak for their tremendous support

Full paper
https://t.co/iaSVZpOuOV